PLC (NASDAQ: TCBP), a biotechnology firm with a market capitalization of $33.08 million engaged in developing gamma-delta T cell therapies, announced today significant progress in its ACHIEVE Phase 2B ...

TC BioPharm (TCBP) announced the first Cohort B patient in the ACHIEVE Phase 2B UK clinical trial, evaluating TCB008 in Acute Myeloid Leukemia, ...

An international study published in the New England Journal of Medicine provides hope for chronic lymphocytic leukemia (CLL) ...

Kura Oncology (KURA) and Kyowa Kirin announced topline results from KOMET-001, the Phase 2 registration-directed trial of ziftomenib, a highly ...

Melvin Mann, diagnosed with chronic myeloid leukemia in 1994, participated in a clinical trial for Imatinib that extended his ...

Laurie Adami's experience with CAR T-cell therapy highlights its potential in treating Non-Hodgkin Lymphoma, emphasizing the ...

These cells fight leukemia by boosting the immune response ... much more work has to be done before the team can head to clinical trials with the hope of improving outcomes for patients with ...

Additional Phase 3 tests are evaluating olverembatinib in newly diagnosed Philadelphia chromosome-positive acute lymphocytic leukemia and ... also plans to run clinical trials that could support ...

Acute lymphocytic leukaemia (ALL) is a cancer of the blood and bone marrow, specifically affecting lymphocytes. The disease progresses rapidly and creates immature blood cells, rather than mature ...

By Hurubie Meko Stephen K. Bannon’s trial on fraud charges will start in March, a week later than previously scheduled, and will include a high-profile lawyer after a judge granted Mr. Bannon ...

She has covered celebrity deaths, lawsuits, and the Hunter Biden gun trial. Erin joined Newsweek in 2024 from the New York Post and had previously worked at News Center Maine. She is a graduate of ...